0001209191-23-047525.txt : 20230828 0001209191-23-047525.hdr.sgml : 20230828 20230828164202 ACCESSION NUMBER: 0001209191-23-047525 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230824 FILED AS OF DATE: 20230828 DATE AS OF CHANGE: 20230828 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ho William Tai-Wei CENTRAL INDEX KEY: 0001830914 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39692 FILM NUMBER: 231216544 MAIL ADDRESS: STREET 1: C/O IN8BIO, INC. STREET 2: 79 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IN8BIO, INC. CENTRAL INDEX KEY: 0001740279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 825462585 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: EMPIRE STATE BUILDING STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 BUSINESS PHONE: (646) 600-6438 MAIL ADDRESS: STREET 1: EMPIRE STATE BUILDING STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 FORMER COMPANY: FORMER CONFORMED NAME: Incysus Therapeutics, Inc. DATE OF NAME CHANGE: 20180510 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-08-24 0 0001740279 IN8BIO, INC. INAB 0001830914 Ho William Tai-Wei C/O IN8BIO, INC. 350 5TH AVE. SUITE 5330 NEW YORK NY 10118 1 1 1 0 President and CEO 0 Common Stock 2023-08-24 4 P 0 23800 1.05 A 2339545 D Common Stock 72999 I By child Common Stock 73000 I By child Common Stock 36500 I See footnote Common Stock 36500 I See footnote Common Stock 36500 I See footnote The shares are held by a relative of the Reporting Person. The Reporting Person has voting power pursuant to a voting proxy. /s/ Jason Minio, Attorney-in-Fact 2023-08-28